FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 267 of 267

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
VCYT Nasdaq Veracyte, Inc. 2830
VERU Nasdaq Veru Inc. 2830
VIR Nasdaq Vir Biotechnology, Inc. 2830
VKTX Nasdaq Viking Therapeutics, Inc. 2830
VRDN Nasdaq Viridian Therapeutics, Inc. 2830
VTGN Nasdaq Vistagen Therapeutics, Inc. 2830
VTRS Nasdaq Viatris Inc. 2830
WUXAY Over the counter WuXi AppTec Co., Ltd. 2830
XCUR Nasdaq Exicure, Inc. 2830
XNCR Nasdaq Xencor, Inc. 2830
XTLB Nasdaq XTL Biopharmaceuticals Ltd. 2830
YARW Nasdaq Yarrow Bioscience, Inc. 2830
ZLAB Nasdaq Zai Lab Limited 2830
ZTS New York Zoetis Inc. 2830
ZURA Nasdaq Zura Bio Limited 2830
ZVRA Nasdaq Zevra Therapeutics, Inc. 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 267 of 267